Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.94%
+21.47%
+3.35%
+1.19%
-0.30%
NWE
NorthWestern Corpora
$60.88
Strengths
Earnings are forecast to grow
Trading below its fair value
Chart
$57.43 (+6.01%)
$52.54 (+15.87%)
$55.33 (+10.03%)
$52.58 (+15.79%)
NWE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Low volume
NWE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
NWE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NWE Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
NWE Earnings
The TTM reflects 12-month period, providing review of NWE financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is NWE current stock price?
What are NWE stock strengths?
What risks are associated with NWE stock?
When is NWE next earnings report?
What is NWE market cap and volume?
What is NWE's current Stock IQ?
Should I buy NWE stock right now?
Is NWE a Strong Buy right now?
What does a 'Strong Buy' rating mean for NWE?
What does a 'Strong Sell' rating mean for NWE?
What factors influence NWE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.94%
+21.47%
+3.35%
+1.19%
-0.30%
NWE
NorthWestern Corpora
Current Price
$60.88
Stock Insights
Strengths
Earnings are forecast to grow
Trading below its fair value
Chart
$57.43 (+6.01%)
$52.54 (+15.87%)
$55.33 (+10.03%)
$52.58 (+15.79%)
NWE Analysts Opinion
NWE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
NWE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
NWE Street view is extremely bullish and have positive views on the near-term outlook
NWE has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Low volume
Average key support and resistance price levels.
NWE Earnings
The TTM data reflects the most recent 12-month period, providing overview of NWE financial performance.
NWE Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
NWE Latest Analysis
Industry Leaders Join Ingenio Cares Mission to Redefine Access Coordination and Value in United States Healthcare. OAK BROOK Ill. Oct. 17 2025 (GLOBE NEWSWIRE) -- Ingenio Care Inc. an AI-driven digital health company today announced the expansion of its distinguished Advisory Board bringing together renowned clinical and business leaders to help guide its next phase of growth. The move reflects Ingenio Care'.s continued momentum in building a connected AI-enabled healthcare network that impr
Fri Oct 17, 2025
Simergent Announces FDA Clearance of the Archimedes™ Home Dialysis System. Archimedes™ a novel automated peritoneal dialysis system which is now FDA 510(k)-cleared enables bloodless dialysis for End Stage Kidney Disease (ESKD) patients in the home or clinic setting. Following a successful human factors usability study affiliated with Northwestern University...
Tue Oct 14, 2025
Bruker Corporation (BRKR) Secures $10M Order for Nuclear Magnetic Resonance Instrumentation. Bruker Corporation (NASDAQ:BRKR) is one of the top stocks in Michael Burrys stock portfolio. On October 3 the company confirmed it had received new orders for advanced Nuclear Magnetic Resonance instrumentation. The $10 million order is from the New York Structural Biology Center (NYSBC) the University of Delaware and Northwestern University. The advanced Nuclear Magnetic [….]
Mon Oct 13, 2025
TEM Expands Partnership With Northwestern Medicine Amid AI Boom. Tempus AI deepens its collaboration with Northwestern Medicine embedding its AI co-pilot David directly into the health systems EHR to boost clinical efficiency.
Fri Oct 10, 2025
Bruker secures $10M in federally funded NMR orders from NYSBC Delaware and Northwestern.
Fri Oct 3, 2025
The Zacks Analyst Blog Highlights Atmos Energy Consolidated Water NorthWestern Energy and Northwest Natural. As economic uncertainty grows ATO CWCO NWE and NWN offer low-beta stability attractive dividends and steady growth making them defensive picks in the utility sector.
Thu Oct 2, 2025
BLRX: A Venture into GBM. By In a highly anticipated event BioLineRx Ltd. (NASDAQ:BLRX) announced a deal to develop a new cancer drug in a joint venture with . Hemispherian is an Oslo Norway-based private biotechnology company developing new cancer therapies. Its lead asset is GLIX1 a first-in-class small-molecule therapeutic targeting DNA repair vulnerabilities in cancer cells. The JV has been established for the development clinical evaluation and commercialization of GLIX1 where Hemispherian
Tue Sep 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.